TELA Bio (TELA) Net Cash Flow (2018 - 2026)

TELA Bio's Net Cash Flow history runs 9 years deep, the most recent figure standing at -$11.3 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 16.23% year-over-year to -$11.3 million; the TTM figure through Mar 2026 stood at -$3.2 million (down 154.74% YoY), while the FY2025 annual figure was -$1.6 million, down 127.45% from the prior year.
• Net Cash Flow was -$11.3 million for Q1 2026 at TELA Bio, down from $21.2 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $35.2 million in Q4 2024 to a low of -$12.2 million in Q4 2022.
• Historically, Net Cash Flow has averaged -$232058.8 across 5 years, with a median of -$9.0 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Net Cash Flow jumped 767.96% in 2023, then tumbled 130.4% in 2024.
• A 5-year view of Net Cash Flow shows it stood at -$12.2 million in 2022, then climbed by 8.38% to -$11.2 million in 2023, then jumped by 413.55% to $35.2 million in 2024, then sank by 39.84% to $21.2 million in 2025, then plunged by 153.28% to -$11.3 million in 2026.
• The last three Net Cash Flow figures came in at -$11.3 million (Q1 2026), $21.2 million (Q4 2025), and -$5.4 million (Q3 2025), per Business Quant data.